Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Neoplasms of the CNS

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 65 articles: HTML format Text format

Single Articles

February 2012
1. JIANG XB M D , Ke C M D, Zhang GH M D, Zhang XH M D, et al
   Brain metastases from hepatocellular carcinoma: Clinical features and prognostic factors.
   BMC Cancer. 2012;12:49.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
2. NOERHOLM M , Balaj L, Limperg T, Salehi A, et al
   RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
   BMC Cancer. 2012;12:22.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. ILIADIS G , Kotoula V, Chatzisotiriou A, Televantou D, et al
   Volumetric and MGMT parameters in glioblastoma patients: Survival analysis.
   BMC Cancer. 2012;12:3.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. YAN T , Skaftnesmo KO, Leiss L, Sleire L, et al
   Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
   BMC Cancer. 2011;11:524.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. LE SCODAN R , Jouanneau L, Massard C, Gutierrez M, et al
   Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death.
   BMC Cancer. 2011;11:395.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
6. DUBROW R , Darefsky AS
   Demographic Variation in Incidence of Adult Glioma by Subtype, United States, 1992-2007.
   BMC Cancer. 2011;11:325.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MAURER GD , Brucker DP, Baehr O, Harter PN, et al
   Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.
   BMC Cancer. 2011;11:315.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. FERLA R , Bonomi M, Otvos L Jr, Surmacz E, et al
   Glioblastoma-derived Leptin Induces Tube Formation and Growth of Endothelial Cells: Comparison with VEGF Effects.
   BMC Cancer. 2011;11:303.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
9. MERK BC , Owens JL, Lopes MB, Silva CM, et al
   STAT6 expression in glioblastoma promotes invasive growth.
   BMC Cancer. 2011;11:184.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
10. LEE SJ , Krauthauser C, Maduskuie V, Fawcett PT, et al
    Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.
    BMC Cancer. 2011;11:144.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FOGARTY G , Morton RL, Vardy J, Nowak AK, et al
    Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial.
    BMC Cancer. 2011;11:142.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SPILLER SE , Logsdon NJ, Deckard LA, Sontheimer H, et al
    Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.
    BMC Cancer. 2011;11:136.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. SEIDEL C , Dorner N, Osswald M, Wick A, et al
    Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.
    BMC Cancer. 2011;11:127.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. VERREAULT M , Strutt D, Masin D, Anantha M, et al
    Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C), doxorubicin (Caelyx) or vincristine.
    BMC Cancer. 2011;11:124.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
15. ZHOU K , Hu D, Lu J, Fan W, et al
    A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population.
    BMC Cancer. 2011;11:104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
16. HU YY , Zheng MH, Cheng G, Li L, et al
    Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
    BMC Cancer. 2011;11:82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. VON BUEREN AO , Oehler C, Shalaby T, von Hoff K, et al
    c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.
    BMC Cancer. 2011;11:74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
18. BRELL M , Ibanez J, Tortosa A
    O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction.
    BMC Cancer. 2011;11:35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MOON KS , Jung S, Lee KH, Hwang EC, et al
    Intracranial metastasis from primary transitional cell carcinoma of female urethra: case report & review of the literature.
    BMC Cancer. 2011;11:23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CAREN H , Djos A, Nethander M, Sjoberg RM, et al
    Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.
    BMC Cancer. 2011;11:66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. KAWAKAMI T , Sameshima T, Hojo H, Koga K, et al
    Synthetic emmprin peptides with chitobiose substitution stimulate MMP-2 production by fibroblasts.
    BMC Cancer. 2011;11:300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. OKUBO Y , Wakayama M, Nemoto T, Kitahara K, et al
    Literature survey on epidemiology and pathology of gangliocytic paraganglioma.
    BMC Cancer. 2011;11:187.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
23. LIU X , Yang JM, Zhang SS, Liu X, et al
    Induction of cell cycle arrest at G1 and S phases and cAMP-dependent differentiation in C6 glioma by low concentration of cycloheximide.
    BMC Cancer. 2010;10:684.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. COHEN JR , Resnick DZ, Niewiadomski P, Dong H, et al
    Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
    BMC Cancer. 2010;10:676.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. WANG P , Zheng H, Jiang X, Zhang W, et al
    Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
    BMC Cancer. 2010;10:661.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
26. COMBS SE , Edler L, Burkholder I, Rieken S, et al
    Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial.
    BMC Cancer. 2010;10:615.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. SHAHI MH , Afzal M, Sinha S, Eberhart CG, et al
    Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.
    BMC Cancer. 2010;10:614.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KESSLER J , Hahnel A, Wichmann H, Rot S, et al
    HIF-1alpha inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
    BMC Cancer. 2010;10:605.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
29. ZHANG W , Murao K, Zhang X, Matsumoto K, et al
    Resveratrol represses YKL-40 expression in human glioma U87 cells.
    BMC Cancer. 2010;10:593.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. MEYNERS T , Heisterkamp C, Kueter JD, Veninga T, et al
    Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.
    BMC Cancer. 2010;10:582.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. TERRILE M , Appolloni I, Calzolari F, Perris R, et al
    PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.
    BMC Cancer. 2010;10:550.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. COMBS SE , Burkholder I, Edler L, Rieken S, et al
    Randomised Phase I/II Study to Evaluate Carbon Ion Radiotherapy versus Fractionated Stereotactic Radiotherapy in Patients with Recurrent or Progressive Gliomas: The CINDERELLA Trial.
    BMC Cancer. 2010;10:533.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SCHREIBER S , Prox-Vagedes V, Elolf E, Brueggemann I, et al
    Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report.
    BMC Cancer. 2010;10:520.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
34. SENFT C , Polacin M, Priester M, Seifert V, et al
    The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.
    BMC Cancer. 2010;10:491.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. VOGL UM , Bojic M, Lamm W, Frischer JM, et al
    Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.
    BMC Cancer. 2010;10:480.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. COMBS SE , Kieser M, Rieken S, Habermehl D, et al
    Randomized Phase II study Evaluating a Carbon Ion Boost applied after Combined Radiochemotherapy with Temozolomide versus a Proton Boost after Radiochemotherapy with Temozolomide in Patients with Primary Glioblastoma - The CLEOPATRA Trial.
    BMC Cancer. 2010;10:478.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. KUAN CT , Wakiya K, Herndon JE 2nd, Lipp ES, et al
    MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
    BMC Cancer. 2010;10:468.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
38. GARCIA JL , Perez-Caro M, Gomez-Moreta JA, Gonzalez F, et al
    Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
    BMC Cancer. 2010;10:454.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. RIEKEN S , Gaiser T, Mohr A, Welzel T, et al
    Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
    BMC Cancer. 2010;10:450.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KONG DS , Kim ST, Lee JI, Suh YL, et al
    Impact of adjuvant chemotherapy for gliomatosis cerebri.
    BMC Cancer. 2010;10:424.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. WANG C , Cao S, Yan Y, Qiao Y, et al
    TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.
    BMC Cancer. 2010;10:415.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
42. EVERS P , Lee PP, Demarco J, Agazaryan N, et al
    Irradiation of the Potential Cancer Stem Cell Niches in the Adult Brain Improves Progression-free Survival of Patients with Malignant Glioma.
    BMC Cancer. 2010;10:384.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
43. NAKABAYASHI H , Yawata T, Shimizu K
    Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.
    BMC Cancer. 2010;10:339.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KOUL N , Sharma V, Dixit D, Ghosh S, et al
    Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells.
    BMC Cancer. 2010;10:328.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. CHENG JX , Liu BL, Zhang X, Lin W, et al
    Health-related quality of life in glioma patients in China.
    BMC Cancer. 2010;10:305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. YANG HW , Menon LG, Black PM, Carroll RS, et al
    SNAI2/Slug Promotes Growth and Invasion in Human Gliomas.
    BMC Cancer. 2010;10:301.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LOH JK , Lieu AS, Chou CH, Lin FY, et al
    Differential expression of centrosomal proteins at different stages of human glioma.
    BMC Cancer. 2010;10:268.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. JACOT W , Gerlotto-Borne MC, Thezenas S, Pouderoux S, et al
    Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.
    BMC Cancer. 2010;10:257.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. XU T , Chen J, Lu Y, Wolff JE, et al
    Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis.
    BMC Cancer. 2010;10:252.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
50. WANG S , Zhao Y, Ruan Z, Chen H, et al
    Association between EGF +61 G/A and glioma risk in a Chinese population.
    BMC Cancer. 2010;10:221.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. DELORENZE GN , McCoy L, Tsai AL, Quesenberry CP Jr, et al
    Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma.
    BMC Cancer. 2010;10:215.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
52. NORDFORS K , Haapasalo J, Korja M, Niemela A, et al
    The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis.
    BMC Cancer. 2010;10:148.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MUCIGNAT-CARETTA C , Denaro L, Redaelli M, D'Avella D, et al
    Protein kinase A regulatory subunit distribution in medulloblastoma.
    BMC Cancer. 2010;10:141.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
54. JARVELA SE , Rantala I, Rodriguez A, Kallio H, et al
    Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.
    BMC Cancer. 2010;10:104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. AMOUREUX MC , Coulibaly B, Chinot O, Loundou A, et al
    Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
    BMC Cancer. 2010;10:91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ARUGA J , Nozaki Y, Hatayama M, Odaka YS, et al
    Expression of ZIC family genes in meningiomas and other brain tumors.
    BMC Cancer. 2010;10:79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
57. PATRU C , Romao L, Varlet P, Coulombel L, et al
    CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.
    BMC Cancer. 2010;10:66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. YAN DF , Yan SX, Yang JS, Wang YX, et al
    Hemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literature.
    BMC Cancer. 2010;10:49.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. MORANDI L , Franceschi E, De Biase D, Marucci G, et al
    Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference.
    BMC Cancer. 2010;10:48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. REITHMEIER T , Graf E, Piroth T, Trippel M, et al
    BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors.
    BMC Cancer. 2010;10:30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
61. REN Y , Zhou X, Mei M, Yuan XB, et al
    MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
    BMC Cancer. 2010;10:27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. DOLOFF JC , Su T, Waxman DJ
    Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+.
    BMC Cancer. 2010;10:487.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. RAHMAN FA , Aziz N, Coverley D
    Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray.
    BMC Cancer. 2010;10:482.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. KIM SJ , Kim JW, Han SW, Oh DY, et al
    Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.
    BMC Cancer. 2010;10:448.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. STEMPFER R , Syed P, Vierlinger K, Pichler R, et al
    Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.
    BMC Cancer. 2010;10:627.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: